Patents by Inventor Junko Oda

Junko Oda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11370232
    Abstract: The medium detection unit is a component constituting an optical path of the detection light, and includes a first optical element disposed on an upper side of the medium transport path and a second optical element disposed on a lower side of the medium transport path so as to face the first optical element, the second optical element has a facing surface that faces the first optical element, the facing surface being located at a position that is not in contact with a medium nipped by both the first roller pair and the second roller pair, and a medium feeding direction by the first roller pair is a direction by which a leading edge of a medium fed out abuts a position upstream in the medium transport direction relative to a position where the detection light is received on the facing surface.
    Type: Grant
    Filed: February 20, 2020
    Date of Patent: June 28, 2022
    Assignee: Seiko Epson Corporation
    Inventors: Junko Ao, Koji Oda, Toshihiro Imae, Soichiro Kii
  • Publication number: 20170080014
    Abstract: The present invention relates to a pharmaceutical composition for relieving pain in a joint disease, including a hyaluronic acid and a pharmaceutically acceptable carrier, in which the hyaluronic acid is cross-linked by cyclizing a double bond in the moiety of a cinnamic acid in a partially amidated hyaluronic acid represented by Formula (1): [Ar—CH?CH—COO—(CH2)n-NH-]m-HA, to form a cycloubutane ring, in which Ar represents an optionally substituted phenyl group, n represents an integer of 2 or 3, HA represents a carboxy residue of the hyaluronic acid, and m represents an amidation ratio of the hyaluronic acid to the total carboxyl group and is in the range of 3 to 50% relative to the total carboxyl group. The pharmaceutical composition of the present invention is an intra-articular formulation that exerts rapid analgesic effects after administration, and shows extremely long durable effects for a human joint disease with only a single administration rather than multiple administrations of a conventional way.
    Type: Application
    Filed: December 6, 2016
    Publication date: March 23, 2017
    Inventors: Hiroyuki Hosokawa, Sooyeol Lim, Junko Oda
  • Publication number: 20140350239
    Abstract: The present invention relates to a pharmaceutical composition for relieving pain in a joint disease, including a hyaluronic acid and a pharmaceutically acceptable carrier, in which the hyaluronic acid is cross-linked by cyclizing a double bond in the moiety of a cinnamic acid in a partially amidated hyaluronic acid represented by Formula (1): [Ar—CH?CH—COO—(CH2)n-NH-]m-HA, to form a cycloubutane ring, in which Ar represents an optionally substituted phenyl group, n represents an integer of 2 or 3, HA represents a carboxy residue of the hyaluronic acid, and m represents an amidation ratio of the hyaluronic acid to the total carboxyl group and is in the range of 3 to 50% relative to the total carboxyl group. The pharmaceutical composition of the present invention is an intra-articular formulation that exerts rapid analgesic effects after administration, and shows extremely long durable effects for a human joint disease with only a single administration rather than multiple administrations of a conventional way.
    Type: Application
    Filed: August 5, 2014
    Publication date: November 27, 2014
    Inventors: Hiroyuki Hosokawa, Sooyeol Lim, Junko Oda
  • Patent number: 8828969
    Abstract: The present invention relates to a pharmaceutical composition for relieving pain in a joint disease, including a hyaluronic acid and a pharmaceutically acceptable carrier, in which the hyaluronic acid is cross-linked by cyclizing a double bond in the moiety of a cinnamic acid in a partially amidated hyaluronic acid represented by Formula (1): [Ar—CH?CH—COO—(CH2)n—NH-]m-HA, to form a cycloubutane ring, in which Ar represents an optionally substituted phenyl group, n represents an integer of 2 or 3, HA represents a carboxy residue of the hyaluronic acid, and m represents an amidation ratio of the hyaluronic acid to the total carboxyl group and is in the range of 3 to 50% relative to the total carboxyl group.
    Type: Grant
    Filed: August 13, 2010
    Date of Patent: September 9, 2014
    Assignee: Seikagaku Corporation
    Inventors: Hiroyuki Hosokawa, Sooyeol Lim, Junko Oda
  • Publication number: 20120142629
    Abstract: The present invention relates to a pharmaceutical composition for relieving pain in a joint disease, including a hyaluronic acid and a pharmaceutically acceptable carrier, in which the hyaluronic acid is cross-linked by cyclizing a double bond in the moiety of a cinnamic acid in a partially amidated hyaluronic acid represented by Formula (1): [Ar—CH?CH—COO—(CH2)n—NH-]m-HA, to form a cycloubutane ring, in which Ar represents an optionally substituted phenyl group, n represents an integer of 2 or 3, HA represents a carboxy residue of the hyaluronic acid, and m represents an amidation ratio of the hyaluronic acid to the total carboxyl group and is in the range of 3 to 50% relative to the total carboxyl group. The pharmaceutical composition of the present invention is an intra-articular formulation that exerts rapid analgesic effects after administration, and shows extremely long durable effects for a human joint disease with only a single administration rather than multiple administrations of a conventional way.
    Type: Application
    Filed: August 13, 2010
    Publication date: June 7, 2012
    Applicant: SEIKAGAKU CORPORATION
    Inventors: Hiroyuki Hosokawa, Sooyeol Lim, Junko Oda